Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC-MS/MS

Journal of Forensic Sciences

Volumn 58, Issue 1, 2013, Pages 195-199

  Jin, Ming J ^a,b   Lee, Jaeick ^a   In, Moon K ^c   Yoo, Hye H ^a,b  

^a Korea Institute of Science and Technology   (South Korea)

^b Hanyang University   (South Korea)

^c Supreme Prosecutors' Office   (South Korea)

Author keywords

497; CP 47; Forensic science; LC MS MS; Metabolism; Spice

Indexed keywords

3 [2 HYDROXY 4 (1,1 DIMETHYLHEPTYL)PHENYL]CYCLOHEXANOL; CANNABINOID; CYCLOHEXANOL DERIVATIVE; PSYCHOTROPIC AGENT;

ARTICLE; BIOTRANSFORMATION; CHEMISTRY; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY;

BIOTRANSFORMATION; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; CYCLOHEXANOLS; HUMANS; MASS SPECTROMETRY; MICROSOMES, LIVER; PSYCHOTROPIC DRUGS;

EID: 84872417570     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2012.02261.x     Document Type: Article

References (15)

1. Weissman A, Milne GM, Melvin LS Jr. Cannabimimetic activity from CP-47, 497, a derivative of 3-phenylcyclohexanol. J Pharma Exp Ther 1982;223(2):516-23.
2. Shim JY, Welsh WJ, Howlett AC. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Biopolymers 2003;71(2):169-89.
3. Pertwee RG, editor. Cannabinoids. In: Handbook of experimental pharmacology. Berlin-Heidelberg, Germany: Springer-Verlag, 2005;168:1-51.
4. Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharma Exp Ther 1988;247(3):1046-51.
5. http://www.deadiversion.usdoj.gov/drugs_concern/spice/spice_cp47497.pdf (accessed August 13, 2012).
6. Melvin LS, Milne GM, Johnson MR, Wilken GH, Howlett AC. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Drug Des Discov 1995;13(2):155-66.
7. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 2010;198(1-3):31-8.
8. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44(5):832-7.
9. http://www.deadiversion.usdoj.gov/fed_regs/rules/2012/fr0301_3.htm (accessed August 13, 2012).
10. Dowling G, Regan L. A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879(3-4):253-9.
11. Möller I, Wintermeyer A, Bender K, Jübner M, Thomas A, Krug O, et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal 2011;3(9):609-20.
12. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int 2010;200(1-3):141-7.
13. Wintermeyer A, Möller I, Thevis M, Jübner M, Beike J, Rothschild MA, et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal Bioanal Chem 2010;398(5):2141-53.
14. Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem 2011;83(11):4228-36.
15. Grigoryev A, Savchuk S, Melnik A, Moskaleva N, Dzhurko J, Ershov M, et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879(15-16):1126-36.